TD Asset Management »

Iovance Biotherapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5M 369k 9.61
2024-06-30 $2.3M 285k 8.02
2024-03-31 $7.5M 505k 14.82
2023-12-31 $2.1M 258k 8.13
2023-09-30 $1.5M 336k 4.55
2023-06-30 $1.2M 168k 7.04
2023-03-31 $713k 117k 6.11
2022-12-31 $733k 115k 6.39
2022-09-30 $1.4M 148k 9.53
2022-06-30 $1.5M 135k 11.04
2022-03-31 $2.7M 161k 16.65
2021-12-31 $2.6M 139k 19.09
2021-09-30 $3.2M 131k 24.66
2021-06-30 $2.9M 131k 22.27
2021-03-31 $5.0M 159k 31.66
2020-12-31 $9.1M 196k 46.40
2020-09-30 $5.7M 172k 32.92
2020-06-30 $4.7M 172k 27.45
2020-03-31 $4.7M 157k 29.93
2019-12-31 $4.6M 168k 27.68
2019-09-30 $3.1M 172k 18.20
2019-06-30 $4.1M 165k 24.52
2019-03-31 $1.0M 110k 9.51
2018-12-31 $974k 110k 8.85
2018-09-30 $1.2M 102k 11.25
2018-06-30 $1.3M 99k 12.80
2018-03-31 $1.3M 76k 16.90